Back to search
HR 254 - 117

Neuromyelitis Optica Spectrum Disorder Consortium Act

Referred to the Subcommittee on Health.

Bill highlights

Votes, text signals, source context, and latest movement from this record.

Bill Text Stats

7
Analyzed sections
$25.0M
Detected dollar total
0
Tax signals
2
Deadlines

Signal counts

Tax density 0.0%
Spending density 71.4%
Studies 6
Spending 5
Benefits 3
Deadline 2
Amendments 1
Privacy 1
Statutory Reference 1

Top agencies

N/A

Statutory references

42 U.S.C. 284 1

House Votes

No House roll call votes have been linked to this bill yet.

Timeline

Feb 2, 2021

Referred to the Subcommittee on Health.

Jan 11, 2021

Introduced in House

Jan 11, 2021

Introduced in House

Jan 11, 2021

Referred to the House Committee on Energy and Commerce.

Affected Sectors

How to read this

Sectors are deterministic matches from official Congress.gov data and cached bill text. They are source-derived signals, not conclusions about intent or economic effect.

Evidence matches count official fields, normalized subjects, cached text snippets, or extracted entities that matched the sector rules.

Impact is a bill-level rollup used for sorting and filtering. It is not an economic impact estimate.

Confidence is the strongest individual match score behind that sector.

Evidence snippets show why a sector matched and can repeat when Congress.gov repeats the same phrase across official fields.

Healthcare
12 evidence matches
Impact 100% Confidence 90%

Health

is amended by ay-inline="no-display-inline" Part B of title IV of the Public Health Service Act ( 42 U.S.C. 284 et seq.) is amended by adding after section 409J the fo

mended by 4. ESTABLISHMENT OF THE NATIONAL NEUROMYELITIS OPTICA SPECTRUM DISORDER CONSORTIUM. Part B of title IV of the Public Health Service Act (42 U.S.C. 284 et seq.) is amended by adding after section 409J the following new section: ``S

Telecom and broadband
5 evidence matches
Impact 94% Confidence 80%

is amended by 4. ESTABLISHMENT OF THE NATIONAL NEUROMYELITIS OPTICA SPECTRUM DISORDER CONSORTIUM. Part B of title IV of the Public Health Service Act (42 U.S.C. 284 et seq.) is amended by adding after section 409J the following new section:

Not later than shment of the National Neuromyelitis Optica Spectrum Disorder Consortium (1) In general Not later than 1 year after the date of the e

Not later than TIS OPTICA SPECTRUM DISORDER CONSORTIUM. ``(a) Establishment of the National Neuromyelitis Optica Spectrum Disorder Consortium.-- ``(1) In general.--Not later than 1 year after the date of the enactment of this section, the S

Technology and data privacy
3 evidence matches
Impact 81% Confidence 70%

eligible for o research funded by the NMOSD Consortium and to make such data and analysis available to researchers. ``(3) Eligible consortia.--To be eligible for a grant under this section, a consortium shall demonstrate the following: ``(A

data collection sights if considered in aggregate than alone. (v) An integrated data collection network, including registry

data collection studies that would be offer greater insights if considered in aggregate than alone. ``(v) An integrated data collection network, including registry and other activities that improve scientific and clinical efficiencies in ac

CBO Cost Estimates

Official Congressional Budget Office cost estimate links associated with this bill through Congress.gov records.

How to read this

CBO estimates are official source documents with their own assumptions, scope, and publication dates. They can score a bill, a version of a bill, or a broader legislative package.

LawLinter stores the source link from Congress.gov and does not replace the CBO document. Use these cards as pointers for source review, not as independent fiscal advice.

CBO context shows source-attributed Congressional Budget Office cost estimates linked from official Congress.gov bill records. It is research context only; read the official CBO source document for assumptions, scope, and dates.

No CBO cost estimate is currently linked for this bill.

Campaign Finance Context

Related FEC/OpenFEC campaign-finance records for lawmakers and candidates tied to this bill through source-attributed legislative relationships. These are not donations to the bill itself.

How to read this

Amounts shown here are campaign-finance totals for sponsor or cosponsor-linked candidates and their committees in the displayed FEC cycle.

They are not donations to this bill, spending on this bill, or proof that money influenced or caused sponsorship, cosponsorship, votes, or legislative outcomes.

If multiple linked lawmakers have FEC records, this section can show multiple candidate cards and separate sponsor/cosponsor rollups.

Campaign-finance context uses source-attributed FEC/OpenFEC records that are related or relevant to the displayed bill, lawmaker, candidate, committee, or legislative relationship through deterministic links. It is research context only, not proof of influence, causation, endorsement, or that money caused a sponsorship, vote, or legislative outcome.

No FEC/OpenFEC campaign-finance context is currently linked for this bill.

Lobbying Context

Related LDA.gov filings where public lobbying activity descriptions reference this bill. These records are source-attributed research context, not evidence of influence or causation.

How to read this

LDA filings are public lobbying disclosure records. LawLinter links them here only when the filing activity text contains an exact-looking reference to this bill.

A filing can mention many issues, clients, agencies, or bills. A match should be treated as a pointer for review, not as a conclusion about why legislation changed or how any lawmaker acted.

Lobbying context uses source-attributed LDA.gov records that appear related to this bill through bill references in public lobbying activity descriptions. It is research context only, not proof of influence, causation, endorsement, lobbying effectiveness, or legislative intent.

No LDA.gov lobbying disclosure context is currently linked for this bill.

Summary

00 Introduced in House May 17, 2021

Neuromyelitis Optica Spectrum Disorder Consortium Act This bill requires the National Institutes of Health to establish a national consortium to coordinate and support research on neuromyelitis optica spectrum disorder, including by awarding grants. This is a neurological disease that can cause blindness, paralysis, and premature death.

Sponsors

Lee, Barbara
Sponsor

Lee, Barbara

Democratic · CA-13 · L000551

Joined Jan 11, 2021
Website
N/A
Phone
N/A
Office
N/A

Amendments

No amendment records are currently available for this bill.
Compiled bill record. Bill pages combine Congress.gov source payloads, normalized relationships, cached text analysis, vote links, and deterministic sector/signal extraction. This is not an official government record or legal advice; use the official source link when accuracy matters.